Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.48 |
| ▸ | PTGES | O14684 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CCR2 | P41597 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | IGF1R | P08069 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10416275 | 0.83 | RAB9A (0.50) | RAB9ANPC1MAPTKMT2AMEN1 | |
| SCHEMBL11440381 | 0.81 | MAPT (0.73) | RAB9ANPC1MAPTKMT2AMEN1 | |
| SCHEMBL10769853 | 0.80 | GAA (0.69) | RAB9ANPC1MAPTMAPK1LMNA | |
| SCHEMBL29994366 | 0.79 | MRGPRX4 (0.57) | RAB9ANPC1KMT2AMEN1 | |
| SCHEMBL4114114 | 0.79 | MAPT (0.67) | RAB9ANPC1MAPTKMT2AMEN1 | |
| SCHEMBL10340655 | 0.77 | RAB9A (0.48) | RAB9ANPC1MAPTKMT2AMEN1 | |
| SCHEMBL11203659 | 0.74 | RAB9A (0.56) | RAB9AMAPTKMT2AMEN1HTT | |
| SCHEMBL1335468 | 0.72 | SIRT1 (0.81) | RAB9ANPC1MAPTKMT2AMEN1 | |
| SCHEMBL1038443 | 0.72 | SMN1; SMN2 (0.57) | RAB9ANPC1MAPTHTTLMNA | |
| SCHEMBL5934468 | 0.72 | TRPV1 (0.71) | RAB9ANPC1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0917822-B1 | Method to control animal ecto-parasites | SUMITOMO CHEMICAL CO (JP) | 2003-10-08 | — | — | EP | disclosed |
| US-6333355-B2 | 1-(2,6-DIFLUOROBENZOYL)-3-(2-FLUORO-4-(1,1,2,3,3,3 -HEXAFLUOROP ROPOXY)PHENYL)UREA; FLEAS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-25 | — | — | US | disclosed |
| US-20010044470-A1 | METHOD TO CONTROL ANIMAL ECTO-PARASITES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-11-22 | — | — | US | disclosed |
| EP-0917822-A1 | Method to control animal ecto-parasites | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044470-A1 | METHOD TO CONTROL ANIMAL ECTO-PARASITES | ENPP3, ENPP1, TUBA3C | RAB9A 1283/4885NPC1 3371/4885MAPT 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.